Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-406.8%Cash Return on Invested Capital
VS
Market
Sector
Industry
History
$ 1.47Close
$ 1.44 - $ 3.32 52-Week Range
Ticker Information
Ticker
MAIACompany Name
MAIA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTMAIA BIOTECHNOLOGY INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MAIA - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | -406.8% | $ -15.77M | $ 3.88M |
| 3/31/2025 | -330.19% | $ -16.32M | $ 4.94M |
| 12/31/2024 | -432.08% | $ -15.7M | $ 3.63M |
| 9/30/2024 | -975.46% | $ -15.79M | $ 1.62M |
| 6/30/2024 | -487.72% | $ -15.42M | $ 3.16M |
| 3/31/2024 | 0% | $ -13.3M | $ -5.76M |
| 12/31/2023 | -2737.32% | $ -13.07M | $ 477.51K |
| 9/30/2023 | -421.73% | $ -11.59M | $ 2.75M |
| 6/30/2023 | -185.47% | $ -12.75M | $ 6.87M |
| 3/31/2023 | -245.33% | $ -12.47M | $ 5.08M |
Key Performance Insights, Last 5 Years
- MAIA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) CROIC stands at -44.91%.
- Over the past 5 years, MAIA BIOTECHNOLOGY INC's average CROIC has been -582.18%.
- The median CROIC for MAIA BIOTECHNOLOGY INC during this period was -406.8%
- MAIA BIOTECHNOLOGY INC reached its highest CROIC over the past 5 years at -44.91%.
- The lowest CROIC recorded by MAIA BIOTECHNOLOGY INC in the same timeframe -2737.32%
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for MAIA BIOTECHNOLOGY INC is calculated as follows: FCF [ $ -4.12M ] / Inv. Capital [ $ 9.18M ]
(=) CROIC [ -44.91% ] MAIA - Cash Return on Invested Capital, Last 5 years
-2737.32%
Minimum
Dec 31, 2023
-44.91%
Maximum
Dec 31, 2021
-582.18%
Average
-406.8%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.82% with a standard deviation of 15.01%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.78% |
| max | 49.3% |
| average | 2.82% |
| median | 5% |
| std | 15.01% |